P53 in B cell chronic lymphocytic leukemia (CLL) and lymphoma with peripheral blood expression along treatment with fludarabine and other treatment regimens

被引：0
|
作者：
Barragan, Carlos Sergio [1 ]
Hansson, Silvia B. [1 ]
Cicchini, Silvina A. [1 ]
Tamashiro, Monica [1 ]
Dinardi, Pablo G. [1 ]
机构：
[1] Hematol & Paliat Care Dept, Buenos Aires, DF, Argentina
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4673
引用
收藏
页码：242B / 242B
页数：1
相关论文
共 50 条
  • [1] Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
    Montillo, Marco
    Ricci, Francesca
    Miqueleiz, Sara
    Tedeschi, Alessandra
    Morra, Enrica
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 41 - 52
  • [2] Treatment of chronic lymphocytic leukemia (CLL) after failure or relapse on fludarabine (FLU) regimens (Rxs).
    Keating, MJ
    OBrien, S
    Lerner, S
    Koller, C
    Beran, M
    Kantarjian, H
    BLOOD, 1996, 88 (10) : 2339 - 2339
  • [3] Chemotherapy combination treatment regimens with fludarabine in chronic lymphocytic leukemia
    Hallek, M
    Eichhorst, BF
    HEMATOLOGY JOURNAL, 2004, 5 : S20 - S30
  • [4] Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia
    Tournilhac, O
    Cazin, B
    Leprètre, S
    Diviné, M
    Maloum, K
    Delmer, A
    Grosbois, B
    Feugier, P
    Maloisel, F
    Villard, F
    Villemagne, B
    Bastit, D
    Belhadj, K
    Azar, N
    Michallet, M
    Manhès, G
    Travade, P
    BLOOD, 2004, 103 (01) : 363 - 365
  • [5] p53 protein expression in chronic lymphocytic leukemia
    Sellmann, Ludger
    Carpinteiro, Alexander
    Nueckel, Holger
    Scholtysik, Rene
    Siemer, Doerte
    Klein-Hipass, Ludger
    Kube, Dieter
    Duerig, Jan
    Duehrsen, Ulrich
    Stanelle, Jens
    Kueppers, Ralf
    LEUKEMIA & LYMPHOMA, 2012, 53 (07) : 1282 - 1288
  • [6] Second malignancies in B-cell chronic lymphocytic leukemia (CLL): Association with CLL but no additional impact with fludarabine or alkylator treatment.
    Flynn, JM
    Howard, RS
    Byrd, JC
    BLOOD, 1999, 94 (10) : 298B - 298B
  • [7] Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response
    Rosenwald, A
    Chuang, EY
    Davis, RE
    Wiestner, A
    Alizadeh, AA
    Arthur, DC
    Mitchell, JB
    Marti, GE
    Fowler, DH
    Wilson, WH
    Staudt, LM
    BLOOD, 2004, 104 (05) : 1428 - 1434
  • [8] Defective expression of ataxia telangiectasia mutated (ATM) as a cause of p53 dysfunction in B-cell chronic lymphocytic leukemia (CLL).
    Pettitt, AR
    Stankovic, T
    Sherrington, PD
    Stewart, GS
    Cawley, JC
    Taylor, AM
    BLOOD, 1999, 94 (10) : 490A - 490A
  • [9] BRCA2 and p53 deletions in chronic lymphocytic leukemia (CLL).
    Navarro, B
    Chin, SF
    Caldas, C
    Catovsky, D
    Garcia-Marco, JA
    BLOOD, 1998, 92 (10) : 226A - 226A
  • [10] Chronic lymphocytic leukemia and treatment resistance in cancer The role of the p53 pathway
    Zenz, Thorsten
    Benner, Axel
    Doehner, Hartmut
    Stilgenbauer, Stephan
    CELL CYCLE, 2008, 7 (24) : 3810 - 3814
12345